P-289 The efficacy and safety of prednisone, cyclophosphamide, doxorubicin and carmustine (PCAB) in relapsed/refractory multiple myeloma in the era of novel therapy, including as a bridge to CAR-T therapy
Saved in:
Published in | Clinical lymphoma, myeloma and leukemia Vol. 23; p. S196 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.09.2023
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2152-2650 2152-2669 |
---|---|
DOI: | 10.1016/S2152-2650(23)01907-9 |